Douma J A J, Verheul H M W, Buffart L M
Department of Medical Oncology, Cancer Center Amsterdam, Netherlands.
Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, Netherlands.
Curr Oncol. 2018 Oct;25(5):e475-e479. doi: 10.3747/co.25.4080. Epub 2018 Oct 31.
Physical function is important for defining treatment strategies in patients with cancer and can be estimated using patient-reported outcomes (pros). Although pros are subjective, physical activity and fitness can be tested objectively with adequate, but more labour-intensive methods that are rarely used in daily clinical practice. To determine whether pros for physical function (pro-pf) accurately predict physical function, we studied their interrelationships with objective measures of physical activity and fitness in patients with cancer who had completed cancer treatment, including adjuvant or neoadjuvant chemotherapy or autologous stem-cell transplantation.
Baseline data from the react (Resistance and Endurance Exercise After Chemotherapy) and exist (Exercise Intervention After Stem-Cell Transplantation) studies were evaluated. In those studies, the effects of an exercise intervention on physical fitness, fatigue, and health-related quality of life in patients with cancer shortly after completion of chemotherapy or stem-cell transplantation were studied. Interrelationships between pro-pf (physical function subscale of the European Organisation for Research and Treatment of Cancer 30-question core Quality of Life Questionnaire), physical activity (accelerometer), and cardiorespiratory fitness (peak oxygen uptake) were assessed using univariable and multivariable multilevel linear mixed-model analyses.
After adjustment for age, sex, and body mass index, the pro-pf was significantly associated with physical activity (β = 1.75; 95% confidence interval: 1.08 to 2.42) and cardiorespiratory fitness (β = 0.10; 95% confidence interval: 0.06 to 0.13). Standardized coefficients were 0.28 and 0.26 respectively, indicating a weak association.
The pro-pf is only weakly associated with objective physical activity and fitness evaluation in patients after curative treatment for cancer. The pro-pf cannot, therefore, be used in clinical practice as a substitute for objective measures of physical function.
身体功能对于确定癌症患者的治疗策略很重要,并且可以使用患者报告结局(PROs)进行评估。尽管PROs是主观的,但身体活动和体能可以通过足够但更耗费人力的方法进行客观测试,而这些方法在日常临床实践中很少使用。为了确定身体功能的PROs(PRO-PF)是否能准确预测身体功能,我们研究了它们与完成癌症治疗(包括辅助或新辅助化疗或自体干细胞移植)的癌症患者身体活动和体能客观测量指标之间的相互关系。
对REACT(化疗后抵抗和耐力运动)和EXIST(干细胞移植后运动干预)研究的基线数据进行评估。在这些研究中,研究了运动干预对化疗或干细胞移植完成后不久的癌症患者体能、疲劳和健康相关生活质量的影响。使用单变量和多变量多级线性混合模型分析评估PRO-PF(欧洲癌症研究与治疗组织30题核心生活质量问卷的身体功能子量表)、身体活动(加速度计)和心肺适能(峰值摄氧量)之间的相互关系。
在对年龄、性别和体重指数进行调整后,PRO-PF与身体活动(β = 1.75;95%置信区间:1.08至2.42)和心肺适能(β = 0.10;95%置信区间:0.06至0.13)显著相关。标准化系数分别为0.28和0.26,表明关联较弱。
在癌症根治性治疗后的患者中,PRO-PF与客观身体活动和体能评估之间的关联较弱。因此,PRO-PF不能在临床实践中用作身体功能客观测量指标的替代指标。